Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.10.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2016
Income Statement [Abstract]      
Revenues
Operating Expenses:      
Research and development 6,562,925 2,936,252 2,933,199
General and administrative 6,446,517 6,063,439 3,783,941
Stock-based compensation - general and administrative 779,701 986,620 732,151
Total Operating Expenses 13,789,143 9,986,311 7,449,291
Operating Loss (13,789,143) (9,986,311) (7,449,291)
Other Income (Expense), Net:      
Interest income 806
Gain on extinguishment of liability 450,000
Other income 818,343
Gain (loss) on revaluation of derivative warrant liability 452,147 (838,219)
Interest expense (15,838) (850,789) (8,994)
Total Other Income (Expense), Net 1,252,505 (398,642) (846,407)
Loss before Income Taxes (12,536,638) (10,384,953) (8,295,698)
Income tax benefit
Net Loss $ (12,536,638) $ (10,384,953) $ (8,295,698)
Net Loss Per Share - Basic and Diluted $ (1.17) $ (1.89) $ (2.29)
Weighted Average Common Shares Outstanding      
Basic and diluted 10,731,875 5,482,494 3,623,208